Yazılar

OpenAI Explores Generative AI Health Tools in Expansion Beyond ChatGPT

/in /tarafından

OpenAI is reportedly exploring consumer health products, including a generative AI-powered personal health assistant, as part of its efforts to expand beyond its core AI offerings, according to Business Insider, citing people familiar with the matter.

The move marks a major step for the ChatGPT developer as it looks to enter the highly regulated and competitive healthcare sector. OpenAI declined to comment on the report.

The company’s healthcare ambitions come after a series of strategic hires earlier this year. In June, OpenAI appointed Nate Gross, cofounder of the physician networking platform Doximity, as head of healthcare strategy, followed by former Instagram executive Ashley Alexander joining as vice president of health products in August.

Speaking at the HLTH conference in October, Gross revealed that ChatGPT attracts around 800 million weekly active users, with a significant number seeking medical or health-related advice through the platform.

OpenAI’s expansion into health mirrors earlier efforts by Google, Amazon, and Microsoft to give consumers more control over their medical data—attempts that largely fell short. Google shut down its Health Records project in 2011, Amazon ended its Halo fitness tracker business in 2023, and Microsoft’s HealthVault also failed to gain widespread adoption.

If realized, OpenAI’s health assistant could integrate generative AI with personalized wellness and medical insights, potentially transforming how consumers manage their health. However, regulatory and ethical challenges around data privacy and medical accuracy are expected to be key hurdles.

Diligent Robotics Recruits Cruise Executives to Expand Beyond Healthcare

/in /tarafından

Diligent Robotics, known for its humanoid robot Moxi that supports hospitals by handling tasks like delivering supplies and lab samples, is gearing up to broaden its focus beyond healthcare logistics. On Thursday, the company announced the addition of two senior executives from Cruise, the autonomous robotaxi firm, signaling a strategic push into wider commercial markets.

Rashed Haq, formerly head of AI and robotics at Cruise, has joined Diligent as chief technology officer. He will lead the development of the company’s AI strategy, leveraging his experience in deploying large-scale autonomous systems. Todd Brugger, Cruise’s former chief of operations, steps in as Diligent’s chief operations officer, where he will be responsible for scaling the company’s operations and commercial growth across various industries.

Andrea Thomaz, CEO of Diligent Robotics, highlighted the value of their expertise, stating that Haq and Brugger’s backgrounds in autonomous vehicle technology are vital as the company expands its robotic solutions beyond hospitals.

Since its launch, Moxi has completed over one million deliveries in more than 30 hospitals across the United States, saving nearly 600,000 staff hours. Looking ahead, Diligent plans to be a leader in embodied AI, targeting the deployment of more than 3,000 robots by 2030.

Hippocratic AI Secures $141 Million in Series B, Valued at $1.64 Billion

/in /tarafından

Hippocratic AI has reached a valuation of $1.64 billion after completing a Series B funding round, raising $141 million. This new round, which brings the company’s total funding to $278 million, was led by Kleiner Perkins, a venture capital firm known for backing tech giants such as Google, Amazon, and Genentech.

Existing investors in the company, including Andreessen Horowitz (A16z), General Catalyst, Premji, NVIDIA, SV Angel, Universal Health Services (UHS), and WellSpan Health, also participated in the round.

The success of Hippocratic AI highlights the thriving sector of AI-driven healthcare solutions, especially following the surge in artificial intelligence innovation, sparked by the release of OpenAI’s ChatGPT in 2022. The company, co-founded by CEO Munjal Shah, includes a team of physicians, healthcare professionals, and AI researchers from prestigious institutions like Johns Hopkins, Stanford, and Microsoft.

Hippocratic AI’s strong funding reflects the growing interest in AI applications for healthcare, signaling continued investment in the industry’s potential to transform medical practices and patient care.